# BTRX-246040 Study in Participants With Parkinson's Disease With Motor Fluctuations

> **NCT03608371** · PHASE2 · COMPLETED · sponsor: **BlackThorn Therapeutics, Inc.** · enrollment: 24 (actual)

## Conditions studied

- Parkinson Disease
- Motor Disorder

## Interventions

- **DRUG:** BTRX-246040
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03608371
- **Lead sponsor:** BlackThorn Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-31
- **Primary completion:** 2019-04-16
- **Final completion:** 2019-04-23
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03608371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03608371, "BTRX-246040 Study in Participants With Parkinson's Disease With Motor Fluctuations". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03608371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*